Renninger Robert 4
4 · Athira Pharma, Inc. · Filed Mar 4, 2025
Insider Transaction Report
Form 4
Renninger Robert
CHIEF FINANCIAL OFFICER
Transactions
- Award
Stock Option (Right to Buy)
2025-03-03+58,500→ 58,500 totalExercise: $0.38Exp: 2035-03-02→ Common Stock (58,500 underlying) - Award
Stock Option (Right to Buy)
2025-03-03+73,350→ 73,350 totalExercise: $0.38Exp: 2035-03-02→ Common Stock (73,350 underlying) - Award
Restricted Stock Units
2025-03-03+39,000→ 39,000 total→ Common Stock (39,000 underlying)
Footnotes (4)
- [F1]The shares subject to the option shall be scheduled to vest monthly over a term of 48 months on the monthly anniversaries of the grant date, subject to the optionee continuing to be a Service Provider (as defined in the Issuer's 2020 Equity Incentive Plan) through the applicable vesting dates.
- [F2]One fourth (1/4th) of shares subject to the option shall be scheduled to vest on the one (1)-year anniversary of the anniversary of the grant date, and one thirty-sixth (1/36th) of the Shares subject to the Option each month thereafter on the same day of the month as the grant date subject to the optionee continuing to be a Service Provider (as defined in the Issuer's 2020 Equity Incentive Plan) through the applicable vesting dates.
- [F3]Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of Issuer's common stock.
- [F4]100% of the RSUs shall vest on the one (1) year anniversary of the grant date, subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2020 Equity Incentive Plan (the "Plan")) through the vesting date.